Trials / Completed
CompletedNCT00718939
Rheos® Diastolic Heart Failure Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- CVRx, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The CVRx® Rheos® Diastolic Heart Failure Trial is a prospective, randomized, double blind trial with up to 60 subjects conducted at up to five centers in Europe. All subjects will be followed up to one year post implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rheos Baroreflex Activation Therapy System | The two (2) Rheos Carotid Sinus Leads conduct the activation energy from the Rheos Implantable Pulse Generator to the baroreceptors located on the left (Left Carotid Sinus Lead) and right (Right Carotid Sinus Lead) carotid sinus. This energy activates the baroreflex by inducing signals that the brain interprets as elevated blood pressure. |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2008-07-21
- Last updated
- 2016-10-21
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00718939. Inclusion in this directory is not an endorsement.